Accelerating Virus-Based Biopharmaceuticals Manufacturing
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/145752 |
Resumo: | Chimeric virus technology has been an explored alternative for vaccination in order to find a safer solution for viral diseases whose virus do not offer the same safety and stability. This is the case of Yellow Fever Virus (YFV) being used as a viral vector against other diseases, such as Dengue fever, Zika infection and Japanese encephalitis. However, this could be difficult due to long process development time span. Hence, the construction of a universal workflow for the purification of YFV is of high interest, so that it is possible to apply it to different chimeric variants. The first part of this thesis presents the evaluation of a purification strategy for YFV involving chromatography in the flow-through mode, performed with a multimodal resin, and a Tangential Flow Filtration step with a 300 kDa cassette. This showed promising results, obtaining a virus recovery yield of 69% and DNA and protein impurity clearance of around 90%. During process development, it is important to have robust analytical tools that allow for fast decision making. The development of an analytical tool for impurity DNA fragment size detection in-process was the second goal of this thesis. Capillary gel electrophoresis conjugated with laser-induced fluorescence (CGE-LIF) was used, and the technique was optimized to identify whether samples are within regulatory authorities’ guidelines for impurity DNA fragment size, i.e., below 200 bp. This technology was used in this work for impurity assessment, both protein and DNA, and for viral protein identification, proving to be a useful analytical not only for process development, but also for final product characterization. Overall, the work presented in this thesis contributed for the optimization of YFV purification process, and for the development of a complementary, highly sensitive, versatile analytical tool for in-process analysis. |
id |
RCAP_7df4d27b6a271f23467c14ffeb0a8e83 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/145752 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Accelerating Virus-Based Biopharmaceuticals Manufacturingflow-through chromatographycapillary electrophoresisflavivirusesviral vectorsDomínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e TecnologiasChimeric virus technology has been an explored alternative for vaccination in order to find a safer solution for viral diseases whose virus do not offer the same safety and stability. This is the case of Yellow Fever Virus (YFV) being used as a viral vector against other diseases, such as Dengue fever, Zika infection and Japanese encephalitis. However, this could be difficult due to long process development time span. Hence, the construction of a universal workflow for the purification of YFV is of high interest, so that it is possible to apply it to different chimeric variants. The first part of this thesis presents the evaluation of a purification strategy for YFV involving chromatography in the flow-through mode, performed with a multimodal resin, and a Tangential Flow Filtration step with a 300 kDa cassette. This showed promising results, obtaining a virus recovery yield of 69% and DNA and protein impurity clearance of around 90%. During process development, it is important to have robust analytical tools that allow for fast decision making. The development of an analytical tool for impurity DNA fragment size detection in-process was the second goal of this thesis. Capillary gel electrophoresis conjugated with laser-induced fluorescence (CGE-LIF) was used, and the technique was optimized to identify whether samples are within regulatory authorities’ guidelines for impurity DNA fragment size, i.e., below 200 bp. This technology was used in this work for impurity assessment, both protein and DNA, and for viral protein identification, proving to be a useful analytical not only for process development, but also for final product characterization. Overall, the work presented in this thesis contributed for the optimization of YFV purification process, and for the development of a complementary, highly sensitive, versatile analytical tool for in-process analysis.A tecnologia de vírus quiméricos tem sido uma alternativa explorada para vacinação em casos de doenças virais cujos vírus não ofereçam a mesma segurança e estabilidade. Este é o caso de alguns flavivírus, utilizando o vírus da febre amarela como vetor viral contra outras doenças, como febre do Dengue, infeção por Zika e encefalite japonesa. Contudo, desenvolvimento de processos consome muito tempo. Portanto, construir um processo de purificação universal para este vírus é de grande interesse, tal como a sua aplicação a diferentes variantes quiméricas. A primeira parte desta tese apresenta uma estratégia de purificação do vírus da febre amarela envolvendo cromatografia em modo negativo, utilizando uma resina multimodal, e ultrafiltração/diafiltração utilizando uma membrana de 300 kDa. Este processo apresentou resultados promissores, obtendo um rendimento de recuperação de vírus de 69% e rendimentos de eliminação de impurezas de DNA e proteína que os 90%. Durante o desenvolvimento de processos, é importante que haja ferramentas analíticas robustas que permitam uma rápida tomada de decisões. O desenvolvimento de uma técnica analítica para deteção de tamanhos de fragmentos de DNA, durante o desenvolvimento de processos, foi o segundo objetivo desta tese. Para isto, a técnica utilizada foi eletroforese capilar com gel, conjugada com um detetor de fluorescência (CGE-LIF), e a técnica foi otimizada para distinguir se as amostras estão dentro dos limites das autoridades regulatórias para tamanho de fragmentos de DNA (abaixo dos 200 pb). Esta tecnologia foi usada nesta tese para avaliação de impurezas, proteínas e DNA, e para identificar proteínas virais, provando ser uma ferramenta analítica útil que pode ser integrada no desenvolvimento de processos e na caracterização do produto final. No geral, esta tese contribuiu para a otimização da purificação do vírus da febre amarela, e para o desenvolvimento de uma ferramenta analítica complementar, sensível e versátil para análise de amostras durante desenvolvimento de processo.Peixoto, CristinaRUNNascimento, Sara Colares Costa Gaspar do2022-11-172025-09-30T00:00:00Z2022-11-17T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/145752enginfo:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:26:23Zoai:run.unl.pt:10362/145752Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:52:14.913439Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
title |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
spellingShingle |
Accelerating Virus-Based Biopharmaceuticals Manufacturing Nascimento, Sara Colares Costa Gaspar do flow-through chromatography capillary electrophoresis flaviviruses viral vectors Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias |
title_short |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
title_full |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
title_fullStr |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
title_full_unstemmed |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
title_sort |
Accelerating Virus-Based Biopharmaceuticals Manufacturing |
author |
Nascimento, Sara Colares Costa Gaspar do |
author_facet |
Nascimento, Sara Colares Costa Gaspar do |
author_role |
author |
dc.contributor.none.fl_str_mv |
Peixoto, Cristina RUN |
dc.contributor.author.fl_str_mv |
Nascimento, Sara Colares Costa Gaspar do |
dc.subject.por.fl_str_mv |
flow-through chromatography capillary electrophoresis flaviviruses viral vectors Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias |
topic |
flow-through chromatography capillary electrophoresis flaviviruses viral vectors Domínio/Área Científica::Engenharia e Tecnologia::Outras Engenharias e Tecnologias |
description |
Chimeric virus technology has been an explored alternative for vaccination in order to find a safer solution for viral diseases whose virus do not offer the same safety and stability. This is the case of Yellow Fever Virus (YFV) being used as a viral vector against other diseases, such as Dengue fever, Zika infection and Japanese encephalitis. However, this could be difficult due to long process development time span. Hence, the construction of a universal workflow for the purification of YFV is of high interest, so that it is possible to apply it to different chimeric variants. The first part of this thesis presents the evaluation of a purification strategy for YFV involving chromatography in the flow-through mode, performed with a multimodal resin, and a Tangential Flow Filtration step with a 300 kDa cassette. This showed promising results, obtaining a virus recovery yield of 69% and DNA and protein impurity clearance of around 90%. During process development, it is important to have robust analytical tools that allow for fast decision making. The development of an analytical tool for impurity DNA fragment size detection in-process was the second goal of this thesis. Capillary gel electrophoresis conjugated with laser-induced fluorescence (CGE-LIF) was used, and the technique was optimized to identify whether samples are within regulatory authorities’ guidelines for impurity DNA fragment size, i.e., below 200 bp. This technology was used in this work for impurity assessment, both protein and DNA, and for viral protein identification, proving to be a useful analytical not only for process development, but also for final product characterization. Overall, the work presented in this thesis contributed for the optimization of YFV purification process, and for the development of a complementary, highly sensitive, versatile analytical tool for in-process analysis. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-17 2022-11-17T00:00:00Z 2025-09-30T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/145752 |
url |
http://hdl.handle.net/10362/145752 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/embargoedAccess |
eu_rights_str_mv |
embargoedAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138114351923200 |